RELOYUS Trademark
RELOYUS is a USPTO trademark filed by Celgene Corporation. Status: Cancelled.
Trademark Facts
| Mark | RELOYUS |
|---|---|
| Serial Number | 88082170 |
| Registration Number | 5709776 |
| Status | Cancelled |
| Filing Date | 2018-08-17 |
| Registration Date | 2019-03-26 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Celgene Corporation |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 18 |
| Latest Event | C8.. on 2025-10-10 |
Goods & Services
Pharmaceutical preparations for use in the treatment of myelofibrosis, polycythemia vera, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system